Thirty Madison

Thirty Madison

Direct-to-consumer telehealth for chronic conditions

Overview

Thirty Madison delivers specialized chronic-condition care through a virtual-first, direct-to-consumer model. The company operates a portfolio of brands—Keeps for men's hair loss, Cove for migraine, Facet for skin conditions, and Nurx for women’s health—offering online consultations with healthcare providers, personalized treatment plans, and home delivery of medications and products. Patients pay for virtual visits and subscribe to regular shipments of prescribed treatments, with revenue coming from consultation fees and subscription orders. Thirty Madison differentiates itself by concentrating on targeted chronic conditions and building a ecosystem of brand-specific care that is accessible online and shipped to patients, supported by a large, over 750,000 active-patients base. Its goal is to make specialized care more affordable and convenient, expanding access to telehealth and ongoing treatment through patient-friendly digital health services.

About Thirty Madison

Simplify's Rating
Why Thirty Madison is rated
C+
Rated C on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Consumer Software

Healthcare

Company Size

201-500

Company Stage

Acquired

Total Funding

$213.5M

Headquarters

New York City, New York

Founded

2017

Get referred to Thirty Madison

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Remedy Meds valued Thirty Madison at just over $500 million in September 2025.
  • The combined platform targets nearly one million patients across men's, women's, and metabolic health.
  • Talkspace demand data showed strong and increasing mental-health demand from Nurx patients since 2022.

What critics are saying

  • Axios reported a January 2025 5% layoff, including the CFO and communications head.
  • Thirty Madison narrowed strategy to Nurx and Keeps, signaling weaker multi-brand optionality.
  • The Remedy Meds all-stock acquisition creates integration risk if Q4 2025 closing drags.

What makes Thirty Madison unique

  • Keeps and Nurx anchor specialized chronic-care brands with focused, repeatable workflows.
  • The 2024 Talkspace partnership bundles therapy into Nurx and Cove care pathways.
  • Remedy Meds wants Thirty Madison's brand portfolio, clinician network, and pharmacy stack.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$213.5M

Above

Industry Average

Funded Over

8 Rounds

Notable Investors:
Acquisition funding comparison data is currently unavailable. We're working to provide this information soon!
Acquisition Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

-10%

1 year growth

2%

2 year growth

0%
Endpoints News
Sep 3rd, 2025
Remedy Meds Acquires Thirty Madison for $500M

Remedy Meds is acquiring virtual care startup Thirty Madison for $500 million. Thirty Madison competes with companies like Hims and Ro.

Endpoints News
Sep 3rd, 2025
Remedy Meds buys virtual health startup Thirty Madison for $500M

Remedy Meds is buying Thirty Madison, a virtual care startup that competes with the likes of Hims and Ro.

PR Newswire
Sep 3rd, 2025
Remedy Meds to Acquire Thirty Madison, Expanding Telehealth Capabilities Across Men's, Women's, and Metabolic Health

/PRNewswire/ -- Remedy Meds, LLC, a consumer virtual-care and pharmacy platform, today announced it has entered into a definitive agreement to acquire Thirty...

The Andalusia Star-News
Sep 3rd, 2025
Remedy Meds to Acquire Thirty Madison, Expanding Telehealth Capabilities Across Men's, Women's, and Metabolic Health

Remedy Meds to acquire Thirty Madison, expanding telehealth capabilities across men's, women's, and metabolic health.

PR Newswire
Jul 25th, 2024
Nurx Survey Reveals More Than Half Of Women Feel Anxious About Reproductive Access, Freedoms

Findings show women are facing longer wait times for essential care, have considered changes to where they live or work due to the current political climate regarding reproductive healthNEW YORK, July 25, 2024 /PRNewswire/ -- Nurx , the healthcare company providing comprehensive specialty care for women, today announced the results of its survey, Reproductive Rights Watch: How Women are Responding to the Shifting Care Landscape. The findings shed light on women's sentiments towards reproductive rights in the U.S. ahead of the 2024 election, showing significant anxiety, changed behaviors, and economic implications among women.Nurx surveyed more than 1,000 women to understand how much agency they feel over their ability to make choices regarding their health and how current national and state reproductive policies influence their decisions. Among the findings, 54% of women surveyed are anxious about their reproductive and sexual freedoms given the political environment, and 49% of women feel anxiety about accessing in-person care for their reproductive and sexual health. The survey also found that an astounding 71% of women have made at least one health-related behavior change — including delaying preventative care visits (25%) or seeking emergency contraception (20%) due to the political climate. Other behavior changes pose a potential economic impact, including considering changing where they work or live (31%)."This data is a powerful reminder of why reproductive rights matter

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Thirty Madison right now.

Find jobs on Simplify and start your career today

We update Thirty Madison's jobs every few hours, so check again soon! Browse all jobs →